Form 4: Invivyd Director Kevin F. McLaughlin Reports Stock Option Grant

Director Kevin F. McLaughlin reports the acquisition of stock options in Invivyd, Inc.

Summary

• Kevin F. McLaughlin, a director of Invivyd, Inc., filed a Form 4 with the SEC.
• The report details the grant of a stock option to McLaughlin on May 20, 2025.
• The option allows McLaughlin to purchase 50,000 shares of Invivyd's common stock at an exercise price of $0.8092 per share.
• The options vest in full on the earlier of May 20, 2026, or the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to continuous service.
• Following the transaction, McLaughlin directly owns options for 50,000 shares.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed neutrally to positively as it aligns management and shareholder interests. The sentiment is moderately positive.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule incentivizes continued service and commitment to the company.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the options.

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with shareholder value creation.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for directors and executives in publicly traded companies, particularly in the biotech sector.
• The vesting schedule of one year is fairly typical, incentivizing continued service.
• The exercise price is set at $0.8092, which may be based on the market price at the time of the grant.

Stakeholder Impact

• Shareholders may view the option grant as a positive sign, aligning the director's interests with the company's success.
• The option grant could potentially dilute existing shareholders if the options are exercised.

Key Dates

Keywords

Form 4, Invivyd, Stock Options, Director, Beneficial Ownership, McLaughlin, Equity, Vesting